Macrogenics Pops on Debut; Trevena Joins IPO Queue
By Jennifer Boggs
Thursday, October 10, 2013
In another piece of good news for the biotech initial public offering (IPO) market, Macrogenics Inc. priced its IPO as expected Thursday, selling 5 million shares at $16 apiece, and then watched as shares (NASDAQ:MGNX) opened 53 percent higher on the first day of trading.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.